These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 19389504)
1. Recurrent and nonrandom DNA copy number and chromosome alterations in Myc transgenic mouse model for hepatocellular carcinogenesis: implications for human disease. Zimonjic DB; Ullmannova-Benson V; Factor VM; Thorgeirsson SS; Popescu NC Cancer Genet Cytogenet; 2009 May; 191(1):17-26. PubMed ID: 19389504 [TBL] [Abstract][Full Text] [Related]
2. Nonrandom cytogenetic alterations in hepatocellular carcinoma from transgenic mice overexpressing c-Myc and transforming growth factor-alpha in the liver. Sargent LM; Zhou X; Keck CL; Sanderson ND; Zimonjic DB; Popescu NC; Thorgeirsson SS Am J Pathol; 1999 Apr; 154(4):1047-55. PubMed ID: 10233843 [TBL] [Abstract][Full Text] [Related]
3. Y chromosome loss and other genomic alterations in hepatocellular carcinoma cell lines analyzed by CGH and CGH array. Park SJ; Jeong SY; Kim HJ Cancer Genet Cytogenet; 2006 Apr; 166(1):56-64. PubMed ID: 16616112 [TBL] [Abstract][Full Text] [Related]
4. Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma. Patil MA; Gütgemann I; Zhang J; Ho C; Cheung ST; Ginzinger D; Li R; Dykema KJ; So S; Fan ST; Kakar S; Furge KA; Büttner R; Chen X Carcinogenesis; 2005 Dec; 26(12):2050-7. PubMed ID: 16000397 [TBL] [Abstract][Full Text] [Related]
5. A comprehensive karyotypic study on human hepatocellular carcinoma by spectral karyotyping. Wong N; Lai P; Pang E; Leung TW; Lau JW; Johnson PJ Hepatology; 2000 Nov; 32(5):1060-8. PubMed ID: 11050057 [TBL] [Abstract][Full Text] [Related]
6. A copy number gain of the 6p arm is linked with advanced hepatocellular carcinoma: an array-based comparative genomic hybridization study. Chochi Y; Kawauchi S; Nakao M; Furuya T; Hashimoto K; Oga A; Oka M; Sasaki K J Pathol; 2009 Apr; 217(5):677-84. PubMed ID: 19097070 [TBL] [Abstract][Full Text] [Related]
7. Pivotal Role of Fatty Acid Synthase in c-MYC Driven Hepatocarcinogenesis. Jia J; Che L; Cigliano A; Wang X; Peitta G; Tao J; Zhong S; Ribback S; Evert M; Chen X; Calvisi DF Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187130 [TBL] [Abstract][Full Text] [Related]
8. The landscape of somatic chromosomal copy number aberrations in GEM models of prostate carcinoma. Bianchi-Frias D; Hernandez SA; Coleman R; Wu H; Nelson PS Mol Cancer Res; 2015 Feb; 13(2):339-47. PubMed ID: 25298407 [TBL] [Abstract][Full Text] [Related]
9. Regulation of glycosylphosphatidylinositol-anchored proteins and GPI-phospholipase D in a c-Myc transgenic mouse model of hepatocellular carcinoma and human HCC. Ritorto MS; Rhode H; Vogel A; Borlak J Biol Chem; 2016 Nov; 397(11):1147-1162. PubMed ID: 27232633 [TBL] [Abstract][Full Text] [Related]
10. Recurrent allelic deletions at mouse chromosomes 4 and 14 in Myc-induced liver tumors. Wu Y; Renard CA; Apiou F; Huerre M; Tiollais P; Dutrillaux B; Buendia MA Oncogene; 2002 Feb; 21(10):1518-26. PubMed ID: 11896580 [TBL] [Abstract][Full Text] [Related]
11. Upregulation of c-myc gene accompanied by PU.1 deficiency in radiation-induced acute myeloid leukemia in mice. Hirouchi T; Takabatake T; Yoshida K; Nitta Y; Nakamura M; Tanaka S; Ichinohe K; Oghiso Y; Tanaka K Exp Hematol; 2008 Jul; 36(7):871-85. PubMed ID: 18375040 [TBL] [Abstract][Full Text] [Related]
12. A transgenic zebrafish liver tumor model with inducible Myc expression reveals conserved Myc signatures with mammalian liver tumors. Li Z; Zheng W; Wang Z; Zeng Z; Zhan H; Li C; Zhou L; Yan C; Spitsbergen JM; Gong Z Dis Model Mech; 2013 Mar; 6(2):414-23. PubMed ID: 23038063 [TBL] [Abstract][Full Text] [Related]
13. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models. Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046 [TBL] [Abstract][Full Text] [Related]
14. Characterization of HCC Mouse Models: Towards an Etiology-Oriented Subtyping Approach. Friemel J; Frick L; Unger K; Egger M; Parrotta R; Böge YT; Adili A; Karin M; Luedde T; Heikenwalder M; Weber A Mol Cancer Res; 2019 Jul; 17(7):1493-1502. PubMed ID: 30967480 [TBL] [Abstract][Full Text] [Related]
15. Nonrandom breakpoints of unbalanced chromosome translocations in human hepatocellular carcinoma cell lines. Keck CL; Zimonjic DB; Yuan BZ; Thorgeirsson SS; Popescu NC Cancer Genet Cytogenet; 1999 May; 111(1):37-44. PubMed ID: 10326589 [TBL] [Abstract][Full Text] [Related]
16. Integrative genomics reveals mechanisms of copy number alterations responsible for transcriptional deregulation in colorectal cancer. Camps J; Nguyen QT; Padilla-Nash HM; Knutsen T; McNeil NE; Wangsa D; Hummon AB; Grade M; Ried T; Difilippantonio MJ Genes Chromosomes Cancer; 2009 Nov; 48(11):1002-17. PubMed ID: 19691111 [TBL] [Abstract][Full Text] [Related]
17. Characterization of copy number alterations in a mouse model of fibrosis-associated hepatocellular carcinoma reveals concordance with human disease. Chappell G; Silva GO; Uehara T; Pogribny IP; Rusyn I Cancer Med; 2016 Mar; 5(3):574-85. PubMed ID: 26778414 [TBL] [Abstract][Full Text] [Related]
18. MYC-regulated genes involved in liver cell dysplasia identified in a transgenic model of liver cancer. Hunecke D; Spanel R; Länger F; Nam SW; Borlak J J Pathol; 2012 Dec; 228(4):520-33. PubMed ID: 22653869 [TBL] [Abstract][Full Text] [Related]
19. Hypomethylation of chromosome 1 heterochromatin DNA correlates with q-arm copy gain in human hepatocellular carcinoma. Wong N; Lam WC; Lai PB; Pang E; Lau WY; Johnson PJ Am J Pathol; 2001 Aug; 159(2):465-71. PubMed ID: 11485905 [TBL] [Abstract][Full Text] [Related]
20. Myelocytomatosis-Protein Arginine N-Methyltransferase 5 Axis Defines the Tumorigenesis and Immune Response in Hepatocellular Carcinoma. Luo Y; Gao Y; Liu W; Yang Y; Jiang J; Wang Y; Tang W; Yang S; Sun L; Cai J; Guo X; Takahashi S; Krausz KW; Qu A; Chen L; Xie C; Gonzalez FJ Hepatology; 2021 Oct; 74(4):1932-1951. PubMed ID: 33896016 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]